SUMMARY Tobacco smoking delays healing of gastric ulcer and may influence duodenal ulceration. Seventy men, all cigarette smokers, were found to have duodenal ulceration at endoscopy. All were advised to stop smoking and received a three-month course of cimetidine. Endoscopy was repeated at-three months (n=63) and at six months (n=56). At three months most (79%) patients showed ulcer healing and there was no difference between men who had and had not stopped smoking. At six months, however, a higher proportion (61% vs 28%, p<O0O5) of smokers (n=38) than ex-smokers (n=18) had duodenal ulceration. This difference reflected a combination of increased ulcer persistence and ulcer relapse. Neither cimetidine nor cigarette smoking nor ulcer healing appeared substantially to affect duodenitis and fixed deformity. We conclude that continued cigarette smoking does not prevent the powerful duodenal ulcer healing effect of cimetidine but does predispose to an increased expectation of duodenal ulceration soon after cimetidine has been stopped.
A relationship between tobacco smoking and peptic ulceration has been suspected for many years. An early retrospective survey' found no evidence of a connection, but soon after, evidence for the association was published.2 3 It has been known for some years that the mortality of peptic ulcer is hi her in smokers than in non-smokers.4 5 Doll et aP found that patients with duodenal ulcers and with gastric ulcers were more often smokers than were eupeptic controls. Ulcer patients smoked mainly cigarettes; non-ulcer controls who did smoke were less often cigarette smokers and more often preferred pipes or cigars.
Gray3 found that stopping smoking led to rapid improvement in the symptoms of peptic ulceration, and since then there have been several studies affirming the adverse effect on healing of continued smoking. This was shown first for gastric ulcer6 and later for duodenal ulcer.7-10 Objective benefits from stopping smoking have rarely been assessed.11
The benefits of continued abstinence from tobacco smoking once duodenal ulcer has healed are even less certain. There is some evidence that continued cigarette smoking predisposes to relapse of duodenal ulcer,12 and At the start of treatment and at three months, all patients were strongly advised to stop cigarette smoking completely and permanently, and not to smoke other forms of tobacco. At three months those who had stopped smoking completely at least six weeks previously, and had remained abstinent, were classified as ex-smokers at three months; all others were designated smokers. At six months, all those who had stopped smoking at least six weeks previously, and had remained abstinent, were classified as ex-smokers at six months. All others were classified as smokers.
Comparisons were made using standard statistical methods.
Results
Sixty three patients were followed up at three months and of these, 50 (79%) showed ulcer healing. Unhealed ulcers were no commoner (19%) in the 47 smokers than in the 16 ex-smokers (25% -p=NS). (Table 1) .
Fifty six patients* were followed up at six months. Thirty eight were smokers of whom 35 smoked throughout the study and three resumed the habit after their three month review. Twenty three smokers at six months (61%) had duodenal ulcers. Sixteen of these had shown ulcer healing at three months and had relapsed; the remaining seven had had duodenal ulcers at three months (duodenal ulcer persistence). Of nine smokers with duodenal ulcers at three months, one was lost to follow up; of the remaining eight, only one healed by six months.
Eighteen patients were ex-smokers at six months; 11 had been ex-smokers at three months also, while the remaining seven stopped smoking after their three month review. Only five (28%) of ex-smokers had duodenal ulcers at six months. This difference in duodenal ulcers between smokers and ex-smokers at six months is significant (p<005). The five exsmokers with duodenal ulcers at six months had all shown ulcer healing at three months. Four exsmokers who had duodenal ulcers at three months * Seven patients were lost to follow up in the first part of the study and seven more in the second part. Two left the armed forces and were unavailable; seven were posted away on duty and five missed follow up because of administrative omissions. Of the seven lost in the second part of the study, five were smokers, four of whose duodenal ulcers had healed at three months; two were ex-smokers, both with healed duodenal ulcers. all healed by six months. In this respect (spontaneous healing rate in second three months) they differed significantly (p<001) from the smokers (seven of eight unhealed, vs). Table 2 shows the relapse rate of the subset of 50 patients whose duodenal ulcers had healed at three months, categorised by smoking status. Relapse at six months was more common (53%) in smokers than in ex-smokers (36%); this difference does not attain significance (0O2<p<03), the numbers involved being rather small. The significant disadvantage in duodenal ulcer experience of smokers compared with ex-smokers at six months emerges when duodenal ulcer relapse and duodenal ulcer persistence are combined (Table 1) .
Smokers were compared with ex-smokers in respect of their initial characteristics at entry to the study, in an attempt to detect any important differences between the groups which might have biased results. Average age, length of history, daily cigarette consumption, number and size of ulcers showed no significant initial differences between groups either at three or six months. Initial duodenal fixed deformity, contact bleeding and duodenitis (type, severity, extent) were statistically indistinguishable in those who would be smokers and ex-smokers at three months. At six months, however, ex-smokers were found originally to have shown a different distribution of type of duodenitis (more 'pepper and salt' and less aphthous), more localised and less generalised duodenitis, and less severe duodenal fixed deformity, than the smokers. Levels (a) Duodenal ulcer relapse The higher incidence of duodenal ulcers in smokers at the end of our study was because of a combination of duodenal ulcer relapse and duodenal ulcer persistence. Duodenal ulcer relapse may occur in as many as 50% of patients within six months of cessation of successful H2 receptor blockade.
Sonnenberg and colleagues'2 found that continued cigarette smoking predisposed to relapse of duodenal ulcers, but that the effect appeared to be prevented by maintenance cimetidine. Sontag et al25
found cigarette smoking to be a major factor in relapse among 370 patients with endoscopically healed duodenal ulcers; even with maintenance cimetidine, smokers relapsed at least as often as non-smokers receiving only placebo. Ex-smokers were not separately assessed. Gough et a126 found smoking to be highly correlated with duodenal ulcer relapse despite maintenance cimetidine or ranitidine. Korman et a122 found duodenal ulcer relapse after H2-receptor mediated healing to be earlier and commoner in cigarette smokers to a degree related to the number of cigarettes smoked daily. The published evidence therefore strongly supports the suggestion that cigarette smoking promotes relapse in patients with healed duodenal ulcers. In our study, the 53% of smokers whose ulcers had relapsed at six months compares with a relapse rate of 36% in ex-smokers; the small numbers involved mean that such a difference is not statistically significant. Bardhan, 28 for example, found no difference in smoking habits between those whose duodenal ulcers resisted or responded to treatment, but more than three quarters of both groups smoked. Frederiksen et al who treated duodenal ulcer patients actively only when there was failure of spontaneous healing, found that a higher proportion of smokers required treatment but the difference compared with non-smokers was not significant. During a subsequent two-year follow up, active (drug) treatment was required more often in smokers than in non-smokers. The Surgeon-General, USA30 characterised the evidence that smoking retarded duodenal ulcer healing as 'suggestive'.
Our finding that all four ex-smokers showed spontaneous ulcer healing while seven of eight smokers failed to heal during the second (no treatment) three months of our study is highly significant. It may be that much of the increased duodenal ulcer morbidity in smokers is because of prolongation of ulcer duration rather than precocious relapse.
Our findings are consistent with the following conclusions: (1) Cimetidine in conventional doses heals the majority of duodenal ulcers in men within three months, and this effect is not prevented by continued cigarette smoking. (2) Three months after stopping cimetidine, men who continue cigarette smoking are more liable than ex-smokers to have duodenal ulcers due both to ulcer persistence and relapse. (3) Duodenitis, judged visually is little affected by cimetidine, by duodenal ulcer healing, by duodenal ulcer relapse, or by stopping smoking.
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